関連する実験動画
Updated: May 4, 2026

07:08
Modeling and Imaging 3-Dimensional Collective Cell Invasion
Published on: December 7, 2011
16.4K
乳がんの集団的侵入には,保存された基礎上皮質プログラムが必要です
Kevin J Cheung1, Edward Gabrielson2, Zena Werb3
1Departments of Cell Biology and Oncology, Center for Cell Dynamics, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Cell
|December 17, 2013
まとめ
乳がんでは,特殊な基礎細胞 (K14+) が集団的侵襲を駆動する. これらの基礎的侵襲的プログラムをターゲットにすることで,癌の転移を制限することができます.
科学分野:
- 腫瘍学 腫瘍学
- 細胞生物学 細胞生物学
- がん研究 がん研究
背景:
- 癌はしばしば凝固した多細胞単位として侵入し,この過程は集団的侵入として知られています.
- 集団的侵襲を誘発する様々な癌細胞亜集団の特定の役割は,依然としてほとんど不明である.
- これらの細胞動態を理解することは,効果的な抗転移戦略の開発に不可欠です.
研究 の 目的:
- 乳がんの原発性腫瘍における集団的侵入を促すのがん細胞のサブ集団を特定する.
- 侵襲性がん細胞のリーダーシップの基礎となる分子メカニズムを解明する.
- 転移の進行を抑制するための潜在的な治療標的を探求する.
主な方法:
- 集団的侵略をモデル化するための3次元 (3D) オルガノイドアッセイの開発と利用.
- 遺伝子発現の分析,特にサイトケラチン-14 (K14) とp63.3のような基礎上皮質マーカーに焦点を当てた.
- 重要な遺伝子 (K14,p63) のノックダウンを含む機能的研究で,侵入に対する影響を評価する.
主要な成果:
- 乳がんの集団的侵襲は,基礎上皮質遺伝子 (K14,p63) を発現する特殊な癌細胞によって導かれます.
- この基礎的侵襲性フェノタイプは,主要なヒト乳がんサブタイプで観察されました.
- ルーミナル癌細胞は,基礎上皮質遺伝子の誘導により,現象的に侵襲的リーダーに変換することができます.
- K14またはp63のノックダウンは,集団的侵略を大幅に抑制し,それらの重要な役割を強調しました.
- エピテリアサブ集団間の異型相互作用は,集団的侵略に不可欠である.
結論:
- 特殊な基礎癌細胞は,がん腫の集団的侵入のリーダーとして機能する.
- K14およびp63発現によって特徴づけられる基礎侵襲プログラムは,転移の重要な要因である.
- この基礎的侵襲プログラムをターゲットにすることで,がん細胞の侵入と転移の拡大を制限する潜在的な戦略が提示されます.
関連する概念動画
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Cell Migration through Invadopodia
2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells
3.8K
3.8K

